Search

everythinglearnresearchcommunity

for

Search:↓

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

India is seeing more cases of gender incongruence and changes in how it's understood and managed legally and medically.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Facial hair is crucial for gender affirmation, but many face financial barriers to achieving desired results.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Gender-diverse people face more depression and anxiety, partly due to stress and lower cortisol levels.

Oral minoxidil can effectively treat hair loss in transgender and gender-diverse individuals.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Transgender and gender-diverse teens need specialized skin and mental health care.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Hair restoration helps transgender patients achieve desired gender appearances.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Feminizing hormone therapy increases kidney filtration rate.

Australia needs better dermatological guidelines for gender-diverse patients.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Few dermatology programs mention gender-affirming care, highlighting a need for better training and visibility.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.